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Abstract Split-hand/foot malformation (SHFM) is a congen-
ital limb defect affecting predominantly the central rays of the
autopod and occurs either as an isolated trait or part of a
multiple congenital anomaly syndrome. SHFM is usually
sporadic, familial forms are uncommon. The condition is
clinically and genetically heterogeneous and shows mostly
autosomal dominant inheritance with variable expressivity
and reduced penetrance. To date, seven chromosomal loci
associated with isolated SHFM have been described, i.e.,
SHFM1 to 6 and SHFM/SHFLD. The autosomal dominant
mode of inheritance is typical for SHFM1, SHFM3, SHFM4,
SHFM5. Autosomal recessive and X-linked inheritance is
very uncommon and have been noted only in a few families.
Most of the known SHFM loci are associated with chromo-
somal rearrangements that involve small deletions or duplica-
tions of the human genome. In addition, three genes, i.e.,
TP63 , WNT10B , and DLX5 are known to carry point muta-
tions in patients affected by SHFM. In this review, we focus
on the known molecular basis of isolated SHFM. We provide
clinical and molecular information about each type of abnor-
mality as well as discuss the underlying pathways and mech-
anism that contribute to their development. Recent progress in
the understanding of SHFM pathogenesis currently allows for
the identification of causative genetic changes in about 50 %
of the patients affected by this condition. Therefore, we pro-
pose a diagnostic flow-chart helpful in the planning of molec-
ular genetic tests aimed at identifying disease causing
mutation. Finally, we address the issue of genetic counseling,
which can be extremely difficult and challenging especially in
sporadic SHFM cases.
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Introduction
Split-hand foot malformation (SHFM) also known as
ectrodactyly is a congenital limb defect affecting predomi-
nantly the central rays of hands and/or feet. It may manifest
either as an isolated trait or part of a multiple congenital
anomaly syndrome. SHFM occurs with the incidence of about
1 per 18,000 liveborn infants and accounts for 8-17 % of all
limbmalformations (Czeizel et al. 1993). SHFM is a clinically
heterogeneous abnormality, which ranges from a relatively
mild defect, such as hypoplasia of a single phalanx or syndac-
tyly, to the aplasia of one or more central digits (i.e., classical
cleft also known as lobster-claw anomaly, see Fig. 1a). In its
most severe form - monodactyly - the defect is characterized
by the aplasia of both central and preaxial rays of the autopod
(Fig. 1b) (Jamsheer 2008). As a consequence, interindividual
and intrafamilial variability of the SHFM is very high. Fur-
thermore, variable expressivity of this feature can be so sig-
nificant, that a different pattern of anomaly is seen in each
limb of the same individual patient (Temtamy and McKusick
1978). The condition is mostly sporadic, familial forms are
uncommon. In the majority of cases SHFM undergoes
autosomal dominant mode of inheritance with reduced
penetrance but other types of inheritance have also been
reported (see Table 1).
In this review, we focus on the known molecular basis of
isolated SHFM. We provide clinical and molecular informa-
tion about each type of abnormality as well as discuss the
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underlying pathways and mechanism that contribute to their
development (see Table 1). Recent progress in the understand-
ing of SHFM pathogenesis currently allows for identification
of causative genetic changes in about 50 % of the patients
affected by this condition. Therefore, we propose a diagnostic
flow-chart helpful in the planning of molecular genetic tests
aimed at identifying disease causing mutation. Finally, we
address the issue of genetic counseling, which can be
extremely difficult and challenging especially in sporadic
SHFM cases.
Developmental aspects of SHFM formation
The developing limb bud consists of two cell layers: highly
proliferating mesenchymal cells covered by the ectodermal
cells. The formation of limb bud is mediated by signaling
molecules produced by three specialized cell groups - the
apical ectodermal ridge (AER), the progress zone (PZ), and
the zone of polarizing activity (ZPA). The interaction between
these three regions determine the patterning of the limb in
three spatial dimensions: proximo-distal, antero-posterior, and
dorso-ventral. A number of signaling molecules and transcrip-
tion factors such as fibroblast growth factors (FGFs), bone
morphogenic proteins (BMPs) or WNT and MSX pro-
teins produced by AER keep the neighboring mesenchy-
mal cells in constant proliferation and undifferentiated
state, giving rise to PZ (Gurrieri et al. 2002). Constantly
proliferating cells of PZ determine the proximo-distal
polarity of the limb bud. Failure in maintaining the
AER affects the formation of the autopod and leads to
the development of SHFM phenotype. Not only genetic,
but also environmental factors that include apoptosis in
the AER can cause SHFM (Sulik and Dehart 1988).
Several genetic factors responsible for SHFM development
have been identified to date.
Known SHFM loci
SHFM1 (7q21)
Split hand/foot malformation type 1 (SHFM1) is caused by
chromosomal rearrangements of the 7q21.3-q22.1 region
(Fig. 2a). They occur mostly as de novo mutational events,
but can also be inherited in an autosomal dominant manner,
with reduced penetrance and variable expression. Genomic
alteration of the SHFM1 locus can be either associated with
isolated or syndromic limb malformation. For instance, senso-
rineural deafness is noted in 35 % of patients, while EEC
symptoms (ectrodactyly-ectodermal dysplasia-cleft lip/palate)
are much less frequent (Tackels-Horne et al. 2001). Aberrations
within this region involve translocations, inversions, duplica-
tions, and most frequently, deletions. The minimal overlapping
region for SHFM1 encompass several genes involved in limb
development, such as DSS1 , DLX5 , and DLX6 (Crackower
et al. 1996; Duijf et al. 2003). Crackower et al. (1996) found
that themurine ortholog ofDSS1 is predominantly expressed in
the mesenchyme of the developing limb bud, facial primordia,
as well as in the branchial arches, genital tubercle, and dermis. It
was proposed that the reduced expression of DSS1 during the
early stages of embryogenesis might be responsible for SHFM
(Crackower et al. 1996). However, the two other genes located
within the 7q21-22 critical region, i.e., DLX5 and DLX6 , were
found to be more attractive candidate genes for SHFM. Both
belong to the members of the Wnt signaling pathway, which is
important in limb skeleton development and morphogenesis
(van Silfhout et al. 2009). Expression of the murine orthologs
- Dlx5 and Dlx6 - has been detected in the AER of the
embryonic limb buds, in the pharyngeal arches, in the osteo-
blasts of developing bones, and in the inter neurons of the basal
forebrain (Simeone et al. 1994; Acampora et al. 1999; Lo
Iacono et al. 2008). Both gene products are critical for the
maintenance of the proliferation of medial AER cell population
in the developing limb bud (Robledo et al. 2002). The role of
DLX5 /DLX6 in limb morphogenesis has been demonstrated in
mouse models, where the double knock-out of both genes
(Dlx5 /Dlx6−/−) resulted in a typical ectrodactyly as well as
craniofacial and inner ear abnormalities. Interestingly, the dele-
tion of neither gene alone has led to ectrodactyly or other limb
phenotype (Robledo et al. 2002). Of note, the SHFM in Dlx5 /
Dlx6−/− null mice could be rescued by solely overexpressing
Dlx5 in the AER suggesting Dlx5 and Dlx6 redundancy in
limb development (Robledo et al. 2002). On the other hand,
overexpression of Dlx5 in wild-type mice has no negative
effect on limb formation. The hypothesized DLX5 and/or
DLX6 biological activity is that they function as repressors of
downstream target genes, which in the absence of both
DLX5 and DLX6 are overexpressed, thereby giving rise
to the reduction of cell proliferation within the AER
(Robledo et al. 2002).
Fig. 1 Schematic presentation of the different anatomical types of SHFM
(a) classical cleft characterized by the aplasia of the central rays of the
autopod; (b) monodactyly characterized by the aplasia of both central and
preaxial rays of the autopod
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The mouse model for SHFM1 varies significantly from the
clinical setting observed in human individuals. While mouse
double Dlx5 /Dlx6−/− knock-out is recessive, human patients
develop the condition if the aberration affects only a single
copy of SHFM1 locus. Consequently, human SHFM1 dele-
tions are inherited in an autosomal dominant manner. Thus,
based on the interspecies differences, one can hypothesize that
human limb development is more sensitive to reduced levels
of DLX5/6 proteins (Robledo et al. 2002). To make things
more complex, haploinsufficiency of SHFM1 locus is not the
only pathomechanism leading to limb defect in human indi-
viduals. Alternative mechanisms occur in the case of chromo-
somal translocations or inversions affecting SHFM1 locus and
include "position effect" on DLX5 /DLX6 genes resulting ei-
ther from the disruption of the regulatory elements or from
changing the regulatory landscape on 7q21 (Merlo et al.
2002). Transcriptional regulation of DLX5 and DLX6 genes
has been investigated by several authors. Lo Iacono et al.
(2008) have shown that DLX proteins and p63 transcription
factor, encoded by TP63 gene, colocalize in the AER and that
p63 acts as an upstream regulator ofDlx5 and Dlx6 transcrip-
tion via binding to their cis-acting regulatory elements at the
promoter level. Heterozygous mutations in TP63 give rise to
limb malformations in multiple congenital syndromes as well
as to isolated SHFM (SHFM4 - described below). Genome-
wide profiling of TP63 cis-regulatory elements and target
genes, reported by Kouwenhoven et al. identified p63 binding
site - SHFM1-BS1, that can function as an enhancer element
controlling the expression of DLX6 , and possibly DLX5 , by
physical interaction with Dlx6 promoter (zebrafish and mice
assay) (Kouwenhoven et al. 2010). The expression of Dlx5 /
Dlx6 is reduced upon p63 inactivation (Lo Iacono et al. 2008)
or disruption of regulatory elements controlled by p63
(Kouwenhoven et al. 2010). Recent studies in the tran-
scriptional regulation of DLX5 /6 resulted in the identi-
fication of additional enhancers located in protein cod-
ing sequences of the neighboring genes. Birnbaum et al.
(2012) have described two novel limb exonic enhancers,
(eExons) DYNC1I1 eExon 15 and 17, that reside prox-
imal to DLX5 /6 . With the use of mouse and zebrafish
transgenic enhancer assays the authors characterized the
enhancer activity of DYNC1I1 eExon 15 in the AER
and DYNC1I1 eExon 17 in the anterior mesenchyme,
and thus showed their regulatory influence on Dlx5 /6
limb expression (Birnbaum et al. 2012). The above
findings gave a new insight to putative genes, regulato-
ry elements and novel disease mechanisms in the
etiopathogenesis of SHFM1.
Recently, Shamseldin et al. (2012) studied a consanguine-
ous family of putative autosomal recessive SHFM and found
that homozygous DLX5 missense mutation located in the
homeodomain was causative for the limb phenotype.
Thus, the authors provided the first strong evidence on
direct DLX5 involvement in the pathogenesis of human
SHFM1 (Shamseldin et al. 2012).
SHFM2 (Xq26)
To date only one family has been reported with X-lined
inheritance of SHFM (Ahmad et al. 1987). The authors de-
scribed a consanguineous Pakistani family of which 36 indi-
viduals manifested full-blown SHFM (33 males and three
females). The patients exhibited monodactylous or
bidactylous hands and typical, but slightly variable feet.
About half of the heterozygous females showed mild
hand and/or foot malformations. Cytogenetic studies
excluded the possibility of X/autosome translocations
(Ahmad et al. 1987). The X-linked inheritance of the
trait in this family was later confirmed by linkage
analysis which mapped the SHFM2 locus to Xq26 (Faiyaz
ul Haque et al. 1993). Two genes located in this region,
FGF13 and TONDU , may potentially be the candidate
genes for SHFM2, however no coding mutations have
been found in the above genes in patients with SHFM
(Vaudin et al. 1999).
Fig. 2 Limbs of the SHFMpatients with different molecular origin of the
defect (a) male proband with a classical cleft of the hands carrying a
balanced chromosomal translocation t(7;12)(q21.2;q21.3) involving
SHFM1 locus; (b , c) female proband carrying a typical 10q24 duplica-
tion of the SHFM3 locus showing ectrodactyly and preaxial polydactyly
of the hands as well as ectrodactyly of the feet; (d) female proband with a
classical cleft of the feet carrying a nonsense heterozygous point mutation
c.G1974A(p.W658X) in the TP63 gene
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SHFM3 (10q24)
The locus for SHFM3 maps to chromosome 10q24 and the
causative rearrangement involves a submicroscopic tandem
duplication spanning a region of 325–570 kb (de Mollerat
et al. 2003; Dimitrov et al. 2010). Duplications of the SHFM3
locus are probably the most frequent cause of SHFM in
humans and accounts for about 20 % of cases (Klopocki
et al. 2012). Several genes potentially contributing to the
SHFM phenotype located within the duplicated region include
DACTYLIN (SFHM3 ), BTRC , POLL , FGF8 , and LBX1 . The
SHFM3 duplication is inherited in an autosomal dominant
manner and associates mostly with the non-syndromic classi-
cal SHFM, which is frequently accompanied with preaxial
abnormalities such as triphalangeal and/or duplicated thumbs
(see Fig. 2b and c) (Everman et al. 2006).
The naturally occurring Dactylaplasia (Dac) mouse is con-
sidered to be an animal model for human SHFM3. Both human
and mouse SHFM3 regions (Dac locus maps to chromosome
19) share a high degree of homology. TheDac mice display the
absence of central digits, hypoplasia or aplasia of metacarpal/
metatarsal bones and syndactyly. The phenotype is inherited in
a semi-dominant manner, i.e., heterozygotes present with the
absence of central digits of hind- and forelimbs, whereas ho-
mozygotes show monodactyly (Johnson et al. 1995; Sidow
et al. 1999). The mechanism that underlies the loss of digits
in Dac mutants involves increased cell death in a specific
portion of the AER. In Dac /+ (heterozygous) mice only the
central part of AER is degenerated, whereas in Dac /Dac
(homozygous) mice both the central and the anterior part of
the AER are affected (Seto et al. 1997; Crackower et al. 1998).
The mechanism by which the duplication of the SHFM3
critical region gives rise to the limb defect remains unknown.
Possible explanations are that either the aberrant DACTYLIN
transcript exhibits a dominant negative effect on wild-type
alleles or that the overexpression of other duplicated genes
takes place, among which BTRC (β-TRCP ) is of particular
interest (de Mollerat et al. 2003). BTRC functions as a
ubiquitination factor of proteins involved in several signaling
transduction pathways such as Wnt/β-catenin, SHH, and
NF-κB (Maniatis 1999). All these pathways are involved in
limb development, therefore dysregulation of BTRC expres-
sion in a dosage dependent manner may be responsible for the
SHFM3 phenotype (de Mollerat et al. 2003). FGF8 also
located within the SHFM3 critical region induces and regu-
lates the limb bud patterning via AER signaling. Fgf8 mouse
ortholog is highly expressed throughout the AER. Its inacti-
vation in early limb ectoderm causes hypoplasia/aplasia of
specific distal skeletal elements and alters the expression of
Shh and Bmp2 genes (Lewandoski et al. 2000; Moon and
Capecchi 2000). To date, no pathogenic mutations have been
reported in any of the putative candidate genes. Another
mechanism that should be taken into consideration is a cis-
acting position effect that gives rise to the skewed expression
of genes flanking the breakpoints of the duplication (de
Mollerat et al. 2003).
SHFM4 (3q27; TP63)
A fourth SHFM locus was mapped to 3q27 region and is
directly associated with mutations in TP63 (also known as
P63 ) gene (Ianakiev et al. 2000). This is the only locus of
monogenic etiology inherited in an autosomal dominant fash-
ion. The protein encoded by TP63 gene is a transcription
factor homologous to tumor suppressor gene TP53 . TP63
plays a crucial role in the embryonic development since it
regulates the formation and differentiation of the AER. It
functions as a key regulator of ectodermal development by
maintaining the proliferative potential of ectodermal cells
(Mills et al. 1999; Yang et al. 1999). TP63 controls the
epithelial stratification process via regulation of AER-
restricted genes (Koster et al. 2004). Mice lacking p63 fail
to form normal ectodermal structures, which is manifested as
developmental abnormalities of the skin, hair, teeth, craniofa-
cial skeleton, mammary glands, and limbs, including
ectrodactyly or other partial limb truncations or amelia
(Mills et al. 1999; Yang et al. 1999). The lack of morpholog-
ically recognizable AER in the limb buds of p63 -null mice
results in amelia and suggests that p63 is essential for the
initiation of this structure (Ianakiev et al. 2000).
TP63 mutations in humans are responsible for approxi-
mately 10-16 % of isolated SHFM cases (see Fig. 2d). On the
other hand, mutations in this gene are found in 93 % of
patients affected by EEC syndrome in which limb
malformations occur as a part of the phenotypic spectrum
(van Bokhoven et al. 2001; de Mollerat et al. 2003a).
SHFM5 (2q31)
Deletions of chromosome 2q31 region encompassing the
entire HOXD gene cluster (HOXD1 -HOXD13 ) has been de-
scribed in patients with SHFM, including monodactyly
(Ramer et al. 1990; Boles et al. 1995; Del Campo et al.
1999). However, Goodman et al. have suggested that a locus
for SHFM5 is associated with the deletions in 2q31 region
encompassing the 5-Mb interval centromeric to EVX2 gene,
which is located upstream of the HOXD cluster (Goodman
et al. 2002). The authors reported two families with limb
malformations. In the first family, father and daughter were
affected with synpolydactyly (SPD) caused by a deletion that
involved 5’ part of the HOXD gene cluster (HOXD9 -
HOXD13 ) and extended only 85 kb upstream of HOXD13
encompassing EVX2 gene. In the second family, the proband
presented with bilateral split foot and deletion at 2q31-q33
comprising the entire HOXD cluster (HOXD1 -HOXD13 ),
EVX2 , DLX1 and DLX2 up to microsatellite marker
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D2S294, located approximately 5 Mb centromeric to EVX2
(Goodman et al. 2002). On the 3’ side of the cluster, the four
remaining HOXD genes (HOXD1 , HOXD3 , HOXD4 ,
HOXD8 ) are not expressed in the developing limbs
(Goodman et al. 2002). Taken together, these findings
indicated that haploinsufficiency of 5’ HOXD cluster
causes SPD, but not SHFM, which is related to a locus
located centromeric to EVX2 on 2q31. Two genes DLX1
and DLX2 , that lie within this locus are putative candidate
genes for ectrodactyly as both are expressed in the AER
and PZ (Goodman et al. 2002). However, neither hetero-
zygous, nor homozygous Dlx1 , Dlx2 , and double Dlx1 /
Dlx2 knock-out mice have limb malformations (Qiu et al.
1997). Furthermore, no pathogenic mutations in those
genes have been identified so far, thus their role in the
pathogenesis of SHFM remains elusive.
SHFM6 (12q13; WNT10B)
To date only three consanguineous families and one sporadic
case exhibiting autosomal recessive inheritance of SHFM
have been reported (Ugur and Tolun 2008; Blattner et al.
2010; Khan et al. 2012; Shamseldin et al. 2012). As men-
tioned above, in one family SHFM was caused by a homozy-
gousDLX5 point mutation in SHFM1 locus (Shamseldin et al.
2012). The three remaining cases of autosomal recessive
SHFM resulted from homozygous mutations in WNT10B , a
gene located within the SHFM6 locus. WNT proteins act as
ligands in a variety of signaling pathways and play a major
role in limb morphogenesis and development (Yang 2003).
Disease causing mutation in this gene was first described by
Ugur and Tolun (2008), who identified a homozygous mis-
sense variant (p.R332W) in all affected members of the Turk-
ish consanguineous family (with the exception of one mildly
affected individual). Importantly, the homozygous mutation
was also identified in one unaffected individual from the same
family, which led to the assumption that the reportedWNT10B
variant is necessary, but not sufficient to produce SHFM.
Therefore, the authors hypothesized the coexistence of a sec-
ond locus that contributes to the phenotype or the presence of
a suppressor mutation in the unaffected individual (Ugur
and Tolun 2008). Another description of an autosomal
recessive SHFM concerned a Swiss patient with a ho-
mozygous 4-bp duplication in WNT10B . Interestingly,
this was the sporadic case that gave a new insight to
the genetic counseling of all patients with sporadic
SHFM, as they were generally considered to have dom-
inantly inherited de novo mutations (Blattner et al.
2010). The recently reported novel homozygous muta-
tion in WNT10B (p.T329R) was detected in a consan-
guineous Pakistani family with autosomal recessive
SHFM in all of the affected family members (Khan
et al. 2012).
Other SHFM loci
Split hand/foot malformation with long bone deficiency
(SHFLD) involving tibia and fibula is most commonly asso-
ciated with the duplication of 17p13.3 locus. The first report
by Lezirovitz et al. (2008) of a large Brazilian family mapped
the SHFLD to an 841 kb interval at 17p13.1-17p13.3
(Lezirovitz et al. 2008). Next, Klopocki et al. (2012) found
that the defect is caused by a tandem duplication and narrowed
down the region to the smallest region of overlap, including
only the single BHLHA9 gene. The authors have investigated
the expression pattern of BHLHA9 mouse and zebrafish
orthologs at different embryonic stages. The results of this
study indicated that Bhlha9 expression in both species was
restricted to the AER of the limb bud mesenchyme. To further
investigate the role of BHLHA9 in limb development the
authors have performed knockdown experiments in zebrafish
embryos, which revealed that loss of protein function resulted
in shortening of the pectoral fins, thus confirming its role in
limb development (Klopocki et al. 2012). Duplication in the
17p13.3 locus is responsible for approximately 12 % of
SHFM without long bone involvement. One of the most
interesting clinical aspects of this study was that SHFLD
related to 17p13.3 locus showed a high degree of non-
penetrance with sex bias, as approximately 50 % of the
duplication carriers (particularly females) were unaffected.
This may be due to the coexistence of another factor related
to a hormone responsive element or modifier on the X-
chromosome that together with 17p13.3 duplication led to
the development of SHFLD (Klopocki et al. 2012).
To date, there has been a single report describing a male
patient who manifested SHFM probably due to a de novo
1 Mb deletion in chromosome 19p13.11. One gene included
in this duplication - EPS15L1 - was suggested by the authors
as a candidate gene for SHFM (Aten et al. 2008). EPS15L1
protein acts as a substrate for the tyrosine kinase activity of the
epidermal growth factor receptor (EGFR), which has been
associated with limb development (Wong et al. 1995). An
indirect evidence for the role of EPS15L1 in SHFM was
provided by Bens et al. (2011) who described a patient with
a de novo deletion partly overlapping with the copy number
variant (CNV) detected by Aten et al. (2008). Interestingly,
both patients shared most of the phenotypic features except
from SHFM and also EPS15L1 gene remained non-deleted in
a patient without limb phenotype (Bens et al. 2011). This
genotype-phenotype correlation substantiates the hypothesis
on EPS15L1 as a potential candidate gene for SHFM, which
nevertheless needs further support.
Frequent SHFM syndromes
As mentioned above, ectrodactyly may occur either as an
isolated malformation or coexists with other congenital
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anomalies such as cleft lip/palate, ectodermal dysplasia or
developmental delay/mental retardation. There are several
relatively frequent syndromes in which ectrodactyly occurs
as one of the multiple congenital anomalies. The most com-
mon involve EEC syndrome (ectrodactyly-ectodermal
dysplasia-cleft lip/palate syndrome), EEC syndrome without
cleft lip/palate, LADD syndrome (lacrimo-auriculo-dento-
digital syndrome), ADULT syndrome (acro-dermato-ungual-
lacrimal-tooth syndrome), CHARGE syndrome or VATER
association (see Table 1).
Diagnostic aspects and genetic counseling
Diagnosis in a patient presenting with SHFM should be
achieved on the basis of both careful clinical examination as
well as relevant cytogenetic and/or molecular tests. Clinical
features and the underlying genetic defects of SHFM have
been described in detail in the above paragraph, hence we
focus here on the diagnostic approach and genetic counseling.
As described above, at least seven SHFM types (i.e., six
basic from SHFM1 to SHFM6 and one additional SHFM/
SHFLD) have been distinguished in the literature (Blattner
et al. 2010; Klopocki et al. 2012). The most common mode of
inheritance for split hand/foot malformation is an autosomal
dominant one with reduced penetrance (Duijf et al. 2003),
although autosomal recessive (Elliott et al. 2005; Blattner
et al. 2010; Shamseldin et al. 2012), as well as X-linked
inheritance (Ahmad et al. 1987) have also been reported.
Sporadic cases with isolated SHFM most likely result from
de novo mutations. In such a setting the recurrence risk for the
proband’s sib is very low, while for the proband’s offspring is
high and reaches 30-50 % (Blattner et al. 2010). Considering
reduced penetrance, variable expression or non-Mendelian
inheritance as well as segregation distortion and sex bias
(Klopocki et al. 2012) with overtransmission of the genetic
alteration from affected fathers to sons (Jarvik et al. 1994), it
becomes clear, that genetic counseling in SHFM cases is
rather difficult and challenging, not only in sporadic but also
in familial cases. Furthermore, many of the SHFM cases seem
to originate from complex set of mutations/chromosomal
aberrations and have to be regarded as two- or multigenic
disorders. Consequently, if genetic counseling in SHFM is to
be reliable and informative it should be based on the panel of
relevant genetic testing. Importantly, for the significant pro-
portion of the SHFM patients who are tested for all known
causative alterations, genetic abnormalities remain uncovered.
Hence, for those patients the exact recurrence risk is unknown
and has to be predicted based on empirical data.
The first tier genetic test should account for the frequency of
the underlying causative SHFM changes. The largest cohort of
SHFM patients described to date comprised 56 cases (Klopocki
et al. 2012). The most frequent genetic abnormalities in this
group were submicroscopic duplications of 10q24.3 (SHFM3)
and 17p13.3 (SHFM/SHFLD) responsible for 20 % and 16 %
of cases, respectively. Based on this finding and on our own
diagnostic experience we propose that SHFM testing should
begin with copy number screening for 10q24 followed by
17p13.3 loci. Array CGH (aCGH) would be the method of
choice as it allows not only for the detection of these changes,
but also for the identification of other unbalanced chromosomal
aberrations such as submicroscopic rearrangements affecting
different loci (i.e., SHFM1 or SHFM5). Since the vast majority
of SHFM related aberrations involve around several hundred
kbs of genomic DNA, the resolution of aCGH platforms does
not have to be particularly high. Routine diagnostic arrays with
the resolution of about 180 k oligonucleotide probes per hap-
loid genome are sufficient for identifying most of the underly-
ing CNVs. Alternatively, aCGH can be substituted by quanti-
tative assays (such as MLPA or qPCR) for all known genomic
SHFM loci. To our knowledge, there are no commercially
available validated diagnostic MLPA or qPCR kits, therefore
such tests have to be developed in-house and as a consequence
they are less reliable. In some SHFM cases the conventional
karyotyping is sufficient for diagnosis, as it can reveal a large
chromosomal aberrations, such as deletions or translocations
involving the 7q21-q22 region (Crackower et al. 1996; Duijf
et al. 2003; Elliot and Evans 2006), namely SHFM1 locus
(Elliott et al. 2005) or deletions of 2q31 (SHFM5) (Goodman
et al. 2002; Elliott et al. 2005). Thus, basic GTG banding is still
useful next to molecular testing, as it is a relatively cheap and
informative assay in a subset of patients linked to SHFM1 or
SHFM5 loci. An important advantage of karyotyping in refer-
ence to aCGH is its ability to detect balanced chromosomal
rearrangements, for instance translocations, which are not in-
frequent in SHFM1 locus. Other patients presenting with iso-
lated SHFM described so far (except for the tiny proportion of
SHFM3) carry normal karyotypes. Conventional GTG banding
should always be considered in syndromic SHFM especially in
the case of association with additional congenital anomalies or
mental retardation which are most common and severe in
SHFM5 cases (Elliot and Evans 2006). Another important
diagnostic test in SHFM patients is the TP63 gene sequencing.
This is because point mutations in this gene give rise to about
10-16 % of isolated SHFM and may occur either de novo or
have autosomal dominant inheritance with a 50 % recurrence
risk. The TP63 mutations show rather complete penetrance but
highly variable expressivity (de Mollerat et al. 2003a).
The recently discovered SHFM6 locus contains the
WNT10B gene (Ugur and Tolun 2008). SHFM6-dependent
defect is inherited in an autosomal recessive manner and is
caused by either homozygous or compound heterozygous
WNT10B mutations. Other autosomal recessive changes
resulting in SHFM were very recently associated in a single
family with homozygousDLX5 mutations in the homeodomain
of the gene (Shamseldin et al. 2012). In the recessive inheri-
tance model, the recurrence risk for proband's sib is 25 %
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Fig. 3 Diagnostic flow-chart
useful in the planning of SHFM
genetic diagnostics. Order of tests
account for the relative
frequencies of different SHFM
causes as well as prices (in the
case of karyotyping vs TP63
sequencing). CNV – copy
number variation, AD –
autosomal dominant, AR –
autosomal recessive, WES –
whole exome sequencing,WGS –
whole genome sequencing
Table 2 Sequences of the
primers used for TP63 , WNT10B
and DLX5 genes amplification
and sequencing
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whereas for proband's offspring is very low, unless there is
consanguinity (Blattner et al. 2010). Noteworthy, autosomal
recessive SHFM seems to be exceptionally rare. So far it has
been reported only in a few, usually consanguineous families.
Therefore, sequencing of WNT10 and DLX5 genes should be
considered at the end of the diagnostic algorithm (for summary
and diagnostic flow-chart proposed by us, see Fig. 3, for a list of
primers routinely used to sequence TP63 ,WNT10B andDLX5
genes, see Table 2).
Recent studies performed on a group of SHFLD cases and
SHFM/SHFLD families have shown that duplications of
17p13.3 with the minimal region of overlap encompassing
only the single BHLHA9 gene are a frequent cause of isolated
SHFM without deficiency of long bones (Klopocki et al.
2012). Importantly, from the clinical point of view, the pene-
trance in this locus is reduced to about 50 % and the abnor-
mality is often inherited from an unaffected parent. Of note, a
strong sex bias has been observed with about 72 % of the
affected individuals being males. On the other hand females
are usually asymptomatic carriers, but once they are affected
they usually present with a more severe phenotype. The
authors estimated the risk for a healthy 17p13.3 duplication
carrier to have an affected male or female offspring as 36 %
and 15 %, respectively (Klopocki et al. 2012).
Development and dissemination of the molecular diagnos-
tic testing, including aCGH have allowed for substantial im-
provement of the diagnostic yield in various groups of pa-
tients, including SHFM or other congenital limb defects.
Genetic and clinical heterogeneity of SHFM contributes to
the exceptionally difficult and challenging genetic counseling,
including the recurrence risk assessment. Therefore, identifi-
cation of the genetic alteration responsible for SHFM in
individual patients is of practical importance for the entire
family. First, it helps the affected or at risk individuals to
understand the nature of the genetic condition as well as the
options in management and preventive or supportive mea-
sures that may be available. Secondly, it provides a solid
foundation for the actual risk estimation allowing for a con-
scious family planning and for prenatal or pre-implantation
diagnosis. Finally, by the exclusion of all known causative
alterations, diagnostic testing creates an opportunity to qualify
unresolved cases for research testing (i.e., whole exome or
whole genome sequencing), thereby contributing to the
discovery of novel causes of SHFM.
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